ArticleBMC medical genomics2022

How does re-classification of variants of unknown significance (VUS) impact the management of patients at risk for hereditary breast cancer?

Ava Kwong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.